RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00034922.xml
PDF herunterladen
Arthritis und Rheuma 2016; 36(01): 37-39
DOI: 10.1055/s-0037-1616802
DOI: 10.1055/s-0037-1616802
Kinder-rheumatologie/Der besondere Fall
Ungewöhnliche Manifestationen einer IgG4-assoziierten Erkrankung
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
22. Dezember 2017 (online)
-
Literatur
- 1 Hamano H, Kawa S, Horiuchi A. High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis. N Engl J Med 2001; 344: 732-738.
- 2 Loock J, Manger B. IgG4 related disease. Z Rheumatol 2013; 72: 151-162.
- 3 Kamisawa T, Anjiki H, Egawa N, Kubota N. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol 2009; 21: 1136-1139.
- 4 Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol 2014; 10: 148-159.
- 5 Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemix disease. Arthritis Rheum 2010; 62: 1755-1762.
- 6 Khosroshahi A, Carruthers MN, Deshpande V. et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 2012; 91: 57-66.
- 7 Yamamoto M, Takahashi H, Naishiro Y. et al. Efficacy of rituximab and other immunosuppressants for IgG4-related disease. Ann Rheum Dis 2012; 71 (Suppl. 03) 290.